Brief: Rennova Health to acquire Pharmacogenetic Laboratory, Genomas
29/09/2016 11:30
Sept 29 (Reuters) - Rennova Health, Inc RNVA.O :
* Rennova Health, Inc. Signs definitive agreement to acquire
Pharmacogenetic Laboratory, Genomas
* Deal for $1.75 million in newly-created series F
convertible preference shares, plus assumption of approximately
$800,000 of existing debt
* Gualberto Ruaño will continue to serve as president,
medical director of Genomas, which will become a wholly owned
subsidiary of Co
Source text for Eikon: urn:newsml:reuters.com:*:nBw8J83cVa
Further company coverage: RNVA.O
((((Bangalore.newsroom@thomsonreuters.com;));))
Recent news on Rennova Health
See all newsBrief: Rennova Health Announces Stock Exchange Agreements With Foxo Technologies For Two Operating Subsidiaries
Brief: Foxo Technologies Enters Into Share Exchange Agreements To Acquire Healthcare Operations From Rennova Health, Inc.
Brief: Rennova Health, Inc. Announces Reverse Stock Split
Brief: Rennova Health Says Purchased, Taken Delivery Of Equipment To Provide Rapid Testing For COVID-19 At 3 Sites
Brief: Rennova Health Completes Agreement To Sell West Palm Beach-Based Clinical Laboratory